Radiolabeled new somatostatin analogs conjugated to DOMA chelator used as targeted tumor imaging agent: synthesis and radiobiological evaluation

详细信息    查看全文

• 作者：Kakali De ; Indranil Banerjee ; Mridula Misra
• 关键词：Somatostatin receptor ; HYNIC ; DOMA ; Octreotide ; 99mTc ; C6 tumor
• 刊名：Amino Acids
• 出版年：2015
• 出版时间：June 2015
• 年：2015
• 卷：47
• 期：6
• 页码：1135-1153
• 全文大小：1,851 KB
• 参考文献：Arnold R, Simon B, Wied M (2000) Treatment of neuroendocrine GEP tumors with somatostatin analogs: a review. Digestion 62:84-1View Article PubMed
  Babich JW, Fischman AJ (1995) Effect of Co-ligand on the biodistribution of 99mTc-labeled hydrazine nicotinic acid derivatized chemotactic peptides. Nucl Med Biol 22:25-0View Article PubMed
  Bakker WH, Albert R, Bruns C, Breeman WAP, Hofland LJ, Marbach P, Pless J, Pralet D, Stolz B, Koper JW, Lamberts SWJ, Visser TJ, Krenning EP (1991) In-111-DTPA-D-Phe1-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors-synthesis, radiolabeling and invitro validation. Life Sci 49(22):1583-591View Article PubMed
  Barbieri F, Florio T (2011) Characterization of the differential efficacy of somatostatin receptor agonists in the inhibition of the growth of experimental gliomas and identification of the intracellular mechanisms involved. Eur J Clin Med Oncol 3:46-3
  Behera A, De K, Chandra S, Chattopadhyay S, Misra M (2011) Synthesis, radiolabelling and biodistribution of HYNIC-Tyr3 octreotide: a somatostatin receptor positive tumour imaging agent. J Radioanal Nucl Chem 290(1):123-29View Article
  De Jong M, Breeman WAP, Bernard BF, Hofland LJ, Srinivasan TJ, Schmidt M, Behe M, Maecke H, Krenning PE (1998) Preclinical comparison of [DTPA0] octreotide, [DTPA0Tyr3] octreotide and [DOTA0Tyr3] octreotide as carriers for somatostatin receptor targeted scintigraphy and radionuclide therapy. Int J Cancer 75:406-11View Article PubMed
  De K, Chadra S, Sarkar B, Ganguly S, Misra M (2010) Synthesis and biological evaluation of 99mTc-DHPM complex : a potential new radiopharmaceutical for lung imaging studies. J Radioanal Nucl Chem 283:621-28View Article
  De K, Bhowmik A, Behera A, Banerjee I, Ghosh MK, Misra M (2012) Synthesis, radiolabeling and preclinical evaluation of a new octreotide analog for somatostatin receptor-positive tumor scintigraphy. J Pept Sci 18:720-30View Article PubMed
  Decristoforo C, Mather JS (1999) Preparation, 99mTc-labeling, and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr3] octreotide. Bioconj Chem 19:431-38View Article
  Decristoforo C, Melendez-Alafort L, Sosabowski JK, Mather SJ (2000) 99mTc-HYNIC-[Tyr3]-octreotide for imaging somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide. J Nucl Med 41(6):1114-119PubMed
  Fischman AJ, Babich JW, Strauss HW (1993) A ticket to ride : peptide radiopharmaceuticals. J Nucl Med 34(12):2253-263PubMed
  Gandomkar M, Najafi R, Shafiei M, Mazidi M, Ebrahimi SES (2007) Preclinical evaluation of Tc-99m/EDDA/tricine/HYNIC0,1-Nal(3), Thr(8)-octreotide as a new analogue in the detection of somatostatin-receptor-positive tumors. Nucl Med Biol 34(6):651-57View Article PubMed
  Graham MM, Menda Y (2011) Radiopeptide imaging and therapy in the United States. J Nucl Med 52:56S-3SView Article PubMed
  Guggenberg EV, Penz B, Kemmler G, Virgolini I, Decristoforo C (2006) Comparison of different methods for radiochemical purity testing of [Tc-99m-EDDA-HYNIC-D-Phe(1), Tyr(3)]-octreotide. Appl Radiat Isot 64:194-00View Article
  Hanaoka H, Tominaga H, Yamada K, Paudyal P, Iida Y, Watanabe S, Paudyal B, Higuchi T, Oriuchi N, Endo K (2009) Evaluation of 64CU-labeled DOTA-d -Phe1-Tyr3-octreotide(64Cu-DOTA-TOC) for imaging somatostatin receptor-expressing tumors. Ann Nucl Med 23:559-67View Article PubMed
  Koenig JA, Edwardson JM, Humphrey PPA (1997) Somatostatin receptors in Neuro2A neuroblastoma cells: operational characteristics. Br J Pharmacol 120(1):45-1View Article PubMed
  Kopecky M, Semecky V, Trejtnar F, Laznicek M, Laznickova A, Nachtigal P (2004) Analysis of accumulation of 99mTc-octreotide and 99mTc-EDDA/HYNIC-Tyr3-octreotide in the rat kidneys. Nucl Med Biol 31:231-39View Article PubMed
  Kwekkeboom DJ, Krenning EP (2002) Somatostatin receptor imaging. Semin Nucl Med 32:84-1View Article PubMed
  Lamszus K, Meverhof W, Westpha M (1997) Somatostatin and somatostatin receptors in the diagnosis and treatment of gliomas. J Neuro Oncol 35:353-64View Article
  Laznickova A, Laznicek M, Trejtnar F, Melicharova L, Suzuki KH, Akizawa H, Arano Y, Yokoyama A (2002) Distribution and elimination characteristics of 111In-DTPA-d -Phe1-octreotide and 111In-DTPA-L-Phe1-octreotide in rats. Eur J Drug Metab Pharmacokin 27:37-3View Article
  Lee TW, Chang SR, Chen ST, Tsai ZT (1998) Convenient solid-phase synthesis of tyr(3)-octreotide. Appl Radiat Isot 49(12):1581-586View Article
  Li WP, Lewis JS, Kim J, Bugaj JE, Johnson MA, Erion JL, Anderson CJ (2002) DOTA-d -Tyr1-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy. Bioconj Chem 13:721-28View Article
  Liu S, Edwards DS (1999) Tc-99m-labeled small peptides as diagnostic radiopharmaceuticals. Chem Rev 99(9):2235-268View Article PubMed
  Maina T, Nock BA, Co
• 作者单位：Kakali De (1)
  Indranil Banerjee (1)
  Mridula Misra (1)
  
  1. Division of Infectious Diseases and Immunology, Nuclear Medicine Department, Council of Scientific and Industrial Research (CSIR)-Indian Institute of Chemical Biology, 4 Raja S C Mullick Road, Kolkata, 700032, West Bengal, India
  
• 刊物类别：Biomedical and Life Sciences
• 刊物主题：Life Sciences
  Biochemistry
  Analytical Chemistry
  Biochemical Engineering
  Life Sciences
  Proteomics
  Neurobiology
  
• 出版者：Springer Wien
• ISSN：1438-2199

文摘

Several receptor-specific radiopeptides have been developed and effective in the diagnosis of malignant diseases. Among them, somatostatin receptor (SSTR) scintigraphy with 111In-DTPA-octreotide has become a tumor diagnostic radiopharmaceutical in nuclear medicine. However, it suffers some drawbacks concerning the imaging properties and elevated radiation burden of 111In. Here, we report the synthesis of radiolabeled two new octapeptides with improved uptake in SSTR2-positive tumors in comparison with 99mTc-HYNIC-Tyr3-octreotide (HYNIC-TOC). Octapeptides were synthesized in high yield by Fmoc solid-phase synthesis and coupling the macrocyclic chelator DOMA(1,4,7-Tri-Boc-10-(carboxymethyl)-1,4,7,10-tetraazocyclododecane-1-yl-monoacetic acid) to these peptides for 99mTc labeling. New peptides DOMA-Asn3-octreotate(DOMA-AATE) and DOMA-Pro3-octreotate(DOMA-PATE) were purified, characterized by RP-HPLC, MALDI-mass, 1H-NMR, 13C-NMR. Labeling was performed by SnCl₂ method to get products with excellent radiochemical purity (97?%). Radiopeptides were found to be substantially stable under physiological condition for 24?h. Internalization and receptor-binding studies were determined in somatostatin receptor-expressing C6-glioma cell line and rat brain cortex membrane and the results compared with HYNIC-TOC as standard. The IC₅₀ values of 99mTc-DOMA-AATE(1.10?±?0.48?nM) and 99mTc-DOMA-PATE(1.76?±?0.06?nM) showed high affinity binding for SSTR2 receptor and they internalized rapidly in C6 cells. Biodistribution and imaging studies were performed in C6 tumor-bearing rat under gamma camera showing significant uptake in kidney, urine and C6 tumor. Radiopeptides exhibited fast blood clearance and rapid elimination through the urinary systems. However, 99mTc-DOMA-AATE exhibited the highest tumor to muscle and tumor to blood uptake ratios among three. These favorable characteristics validate 99mTc-DOMA-AATE as a more promising 99mTc-radiotracer than 99mTc-DOMA-PATE, 99mTc-HYNIC-TOC for SSTR2-positive tumor scintigraphy.